Multistate implementation of guideline-based cardiac resuscitation systems of care: Description of the HeartRescue Project - 04/10/13

Doi : 10.1016/j.ahj.2013.05.022

Sean van Diepen, MD, MSc ^a,^{^{j
On behalf of the HeartRescue Group.}}, Benjamin S. Abella, MD ^b,^{^⁎,}^{^{j
On behalf of the HeartRescue Group.}} , Bentley J. Bobrow, MD ^c,^{^{j
On behalf of the HeartRescue Group.}}, Graham Nichol, MD ^d,^{^{j
On behalf of the HeartRescue Group.}}, James G. Jollis, MD ^e,^{^{j
On behalf of the HeartRescue Group.}}, Joan Mellor, BA ^f,^{^{j
On behalf of the HeartRescue Group.}}, Edward M. Racht, MD ^g,^{^{j
On behalf of the HeartRescue Group.}}, Demetris Yannopoulos, MD ^h,^{^{j
On behalf of the HeartRescue Group.}}, Christopher B. Granger, MD ^e,^{^{j
On behalf of the HeartRescue Group.}}, Michael R. Sayre, MD ^i,^{^{j
On behalf of the HeartRescue Group.}}
^a Divisions of Critical Care and Cardiology, University of Alberta, Edmonton, Alberta, Canada
^b University of Pennsylvania, Philadelphia, PA
^c University of Arizona, Phoenix, AZ
^d University of Washington, Seattle, WA
^e Duke University, Durham, NC
^f Medtronic Foundation, Minneapolis, MN
^g American Medical Response, Greenwood Village, CO
^h University of Minnesota, Duluth, MN
ⁱ Ohio State University, Columbus, OH

^⁎Reprint requests: Benjamin S. Abella, MD, Department of Emergency Medicine, 3400 Spruce St, Ground Ravdin, Philadelphia, PA 19104.

Résumé

Background

There is large and significant regional variation in out-of-hospital cardiac arrest (OHCA), and despite advances in treatment, survival remains low. The American Heart Association has called for the creation of integrated cardiac resuscitation systems of care capable of measuring and improving evidence-based care from bystanders through to hospital discharge.

Methods

The HeartRescue Project was initiated in 2010 by the Medtronic Foundation in collaboration with 5 academic medical centers and American Medical Response. The HeartRescue Project aims to develop regional cardiac resuscitation systems of care that will implement guideline-based best practice bystander, prehospital, and hospital care with standardized data reporting linked to outcomes. The primary goal is to improve collective OHCA survival by 50% over 5 years.

Results

The total population in the 5 participating states is 41.1 million. At baseline, the HeartRescue Project covers approximately 26.1 million people (63.6%) and has engaged 767 emergency medical services agencies and 269 hospitals. Data will be collected for quality improvement, to inform provider feedback, and serve to define effective strategies to improve cardiac arrest care.

Conclusion

The HeartRescue Project is the largest public health initiative of its kind focused entirely on cardiac arrest outcomes. The project is designed to significantly improve OHCA survival by implementing and measuring model systems of care for cardiac resuscitation.

Le texte complet de cet article est disponible en PDF.

Plan

The HeartRescue Project: distinguishing features, goals, and implementation barriers

Participating HeartRescue partner strengths and state demographic information

Organizational plan, definitions, and registry for future academic inquiries

Implementing plans to improve OHCA survival

Implementation of evidence-based care

Linking the chain of survival

Timothy D. Henry, MD served as guest editor for this article.

Export

Vol 166 - N° 4

P. 647 - octobre 2013 Retour au numéro

Article précédent

Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries
Daniel J. Corsi, S.V. Subramanian, Clara K. Chow, Martin McKee, Jephat Chifamba, Giles Dagenais, Rafael Diaz, Romaina Iqbal, Roya Kelishadi, Annamarie Kruger, Fernando Lanas, Patricio López-Jaramilo, Prem Mony, V. Mohan, Alvaro Avezum, Aytekin Oguz, M. Omar Rahman, Annika Rosengren, Andrej Szuba, Wei Li, Khalid Yusoff, Afzalhussein Yusufali, Sumathy Rangarajan, Koon Teo, Salim Yusuf

| Article suivant

Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the I_f inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Multistate implementation of guideline-based cardiac resuscitation systems of care: Description of the HeartRescue Project - 04/10/13

Résumé

Background

Methods

Results

Conclusion

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL